BMY 250103 59.00P (BMY250103P59000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

BMY250103P59000

Watchlist

2.35
-0.65-21.67%

15min DelayClose Jan 3 16:00 ET

2.35High2.32Low

Intraday

5D
Daily

News

Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Kevin TraversJan 3 16:19 ET
Friday? More Like Grinch Day | Wall Street Today
Kevin TraversJan 3 16:02 ET
Santa Claus Came Without Rallying the Troops | Live Stock
Kevin TraversJan 3 10:45 ET
Bristol Myers Squibb to Present at J.P. Morgan's 43rd Annual Healthcare Conference
BusinesswireJan 3 06:59 ET
Update: Market Chatter: Drug Companies to Raise Prices on 250 Branded Drugs in 2025
MT NewswiresJan 3 04:17 ET
Bristol-Myers Squibb Options Spot-On: On January 2nd, 391.89K Contracts Were Traded, With 617.52K Open Interest
Moomoo NewsJan 2 16:30 ET

Comments

Kevin Travers

Dec 27, 2024 15:23

Columns So Much For The Man With the Bag | Wall Street Today

The market decisively fell Friday, with the indexes pulling back. On Thursday, $Apple (AAPL.US)$ hit an all-time high of $260, just below the $4 T market cap. Friday, the market pulled back, with other big tech names joining Apple in pilling down indices. It is looking bleak for a "Santa Clause Rally" that sees the last seven sessions or so of the trading year end in an overall gain.
After the 4 pm close, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.77...

Can the Santa Claus rally happen after the Fed's hawkish cut?

Meltyy

Dec 17, 2024 01:56

📌 1 PDUFA this weekand 6 more upcoming this month! 🚀

🔔 This Week’s PDUFA:
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...

10xStockPicks

Dec 15, 2024 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

Meltyy

Dec 10, 2024 05:36

🚀 10 Upcoming PDUFAs in December! ❄️

Buckle up! See FDA PDUFA update 👇
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont oral solution
$BeiGene (BGNE.US)$ ⇨ Tisleli...

Meltyy

Dec 5, 2024 06:32

🚀 12 upcoming PDUFAs in December ❄️

Buckle up! See FDA PDUFA update 👇🧵
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinece...